Mayinglong Pharmaceutical Group (600993.SS) Earnings Analysis
Mayinglong Pharmaceutical Group (600993.SS) has no confirmed upcoming earnings date. Trailing P/E 17.29.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600993.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600993.SS. This page updates as the calendar is published.
600993.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-25 | 0.19 CNY | n/a | n/a | n/a |
| 2025-10-30 | 0.3661 CNY | n/a | n/a | n/a |
| 2025-04-25 | 0.1638 CNY | n/a | n/a | n/a |
| 2025-04-02 | 0.47 CNY | n/a | n/a | n/a |
| 2024-10-25 | 0.3378 CNY | n/a | n/a | n/a |
| 2024-08-23 | 0.265 CNY | n/a | n/a | n/a |
600993.SS valuation and analyst view
| Trailing P/E | 17.29 |
|---|---|
| Trailing EPS | 1.361 CNY |
| Price / book | 2.24 |
| Dividend yield | 2.62% |
| Market cap | 10.12B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Mayinglong Pharmaceutical Group (600993.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600993.SS. This page updates as the calendar is published.
Did 600993.SS beat earnings last quarter?
Consensus estimate data was not available for 600993.SS's 2026-04-25 report.
What is 600993.SS's current P/E ratio and EPS?
600993.SS trades at a trailing P/E of 17.29 on trailing EPS of 1.3610867958217086 CNY.
What do analysts rate 600993.SS?
600993.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.